Biophytis SA Total Assets 2011-2026 | BPTS

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Biophytis SA

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
12 M	22 M	34.9 M	27.2 M	17.7 M	21.9 M	25.9 M	8.39 M	13.5 M	387 K	628 K	1.21 M	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
34.9 M	387 K	15.5 M

Quarterly Total Assets Biophytis SA

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	36.3 M	-	-	-	27.2 M	-	-	-	17.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.3 M	17.7 M	27 M

Total Assets of other stocks in the Biotechnology industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.03 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	396 M	-	1052.0 %	$ 415 M	USA
Adaptive Biotechnologies Corporation ADPT	539 M	$ 18.46	-0.22 %	$ 2.72 B	USA
Amgen AMGN	91.8 B	$ 344.63	0.8 %	$ 185 B	USA
Arrowhead Pharmaceuticals ARWR	1.39 B	$ 70.06	1.05 %	$ 9.37 B	USA
I-Mab IMAB	6.33 B	-	-	$ 866 M	China
Biogen BIIB	28 B	$ 179.46	-0.24 %	$ 26.1 B	USA
Aytu BioScience AYTU	124 M	$ 2.7	3.85 %	$ 17 M	USA
Alexion Pharmaceuticals, Inc. ALXN	18.1 B	-	-	$ 40.3 B	USA
Adagene ADAG	89.3 M	$ 2.6	-5.45 %	$ 146 M	China
Midatech Pharma plc MTP	14.8 M	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	3.11 B	$ 9.78	0.93 %	$ 1.57 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	15.2 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	826 M	-	-	$ 3.67 B	USA
Alterity Therapeutics Limited ATHE	41.4 M	$ 3.14	-0.95 %	$ 7.55 B	Australia
Can-Fite BioPharma Ltd. CANF	9.12 M	$ 4.32	7.67 %	$ 9.4 B	Israel
Acorda Therapeutics ACOR	109 M	-	-24.86 %	$ 820 K	USA
Aptose Biosciences APTO	10.1 M	-	-45.71 %	$ 1.2 M	Canada
Acasti Pharma ACST	72 M	-	4.01 %	$ 150 M	Canada
Compugen Ltd. CGEN	115 M	$ 1.83	-0.3 %	$ 164 M	Israel
Aeglea BioTherapeutics AGLE	608 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	242 M	$ 1.41	-	$ 264 M	USA
Albireo Pharma ALBO	302 M	-	-0.23 %	$ 916 M	USA
Celldex Therapeutics CLDX	792 M	$ 24.98	1.54 %	$ 1.61 M	USA
Институт стволовых клеток человека ISKJ	1.51 B	-	-	-	Russia
Allena Pharmaceuticals ALNA	34.8 M	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	1.18 B	$ 226.97	0.38 %	$ 5 B	Danmark
Ampio Pharmaceuticals AMPE	5.74 M	-	-11.43 %	$ 502 K	USA
Cellectis S.A. CLLS	384 M	$ 3.86	1.72 %	$ 116 M	France
Applied Molecular Transport AMTI	107 M	-	-	$ 10.1 M	USA
Aravive ARAV	62.2 M	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	22.5 B	$ 109.35	-3.87 %	$ 27.2 B	Germany
Athira Pharma ATHA	58.8 M	-	-	$ 269 M	USA
Aeterna Zentaris AEZS	35.1 M	-	5.93 %	$ 314 M	Canada
Autolus Therapeutics plc AUTL	783 M	$ 1.38	0.73 %	$ 352 M	Britain
Corcept Therapeutics Incorporated CORT	841 M	$ 42.1	5.59 %	$ 4.35 B	USA
AgeX Therapeutics AGE	12 M	-	-10.17 %	$ 12.2 K	USA
AVROBIO AVRO	101 M	-	1083.1 %	$ 745 M	USA
Catalyst Pharmaceuticals CPRX	851 M	$ 24.77	1.93 %	$ 2.93 B	USA
Cardiff Oncology CRDF	97.2 M	$ 1.7	-3.14 %	$ 81 M	USA
Akouos AKUS	279 M	-	0.23 %	$ 488 M	USA
Adaptimmune Therapeutics plc ADAP	283 M	-	-15.15 %	$ 60.3 M	Britain
Brickell Biotech BBI	11.6 M	-	-5.38 %	$ 6.06 M	USA
Amneal Pharmaceuticals AMRX	3.5 B	$ 13.96	2.01 %	$ 4.31 B	USA
AIkido Pharma AIKI	47.1 M	-	1.93 %	$ 17.4 M	USA
Atreca BCEL	155 M	-	-11.76 %	$ 5.79 M	USA
CureVac N.V. CVAC	1.16 B	-	-	$ 867 M	Germany
Acer Therapeutics ACER	11.6 M	-	2.71 %	$ 14 M	USA
BioCryst Pharmaceuticals BCRX	490 M	$ 6.58	-	$ 1.36 B	USA